Piperine regulates glucose metabolism disorder in HepG2 cells of insulin resistance models via targeting upstream target of AMPK signaling pathway.
10.19540/j.cnki.cjcmm.20161222.059
- Author:
Chun-Ping WAN
1
;
Ya-Gai WEI
1
;
Xiao-Xue LI
1
;
Li-Jun ZHANG
1
;
Rui YANG
1
;
Zhao-Ri-Ge-Tu BAO
1
Author Information
1. Immunopharmacology of Traditional Chinese Medicine, the Third-Grade Laboratory of the State Administration of Traditional Chinese Medicine, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China.
- Publication Type:Journal Article
- Keywords:
AMPK signaling pathway;
adiponectin;
insulin resistance;
leptin;
piperine
- From:
China Journal of Chinese Materia Medica
2017;42(3):542-547
- CountryChina
- Language:Chinese
-
Abstract:
To investigate the effect of piperine on the disorder of glucose metabolism in the cell model with insulin resistance (IR) and explore the molecules mechanism on intervening the upstream target of AMPK signaling pathway. The insulin resistance models in HepG2 cells were established by fat emulsion stimulation. Then glucose consumption in culture supernatant was detected by GOD-POD method. Enzyme-linked immunosorbent assay(ELISA) was used to measure the levels of leptin(LEP) and adiponectin(APN) in culture supernatant; Real-time quantitative PCR was used to assess the mRNA expression of APN and LEP; and the protein expression levels of LepR, AdipoR1, AdipoR2 and the activation of AMPK signaling pathway were detected by Western blot analysis. The results showed that piperine, rosiglitazone and AMPK agonist AICAR could significantly elevate the glucose consumption in insulin resistance cell models, enhance the level of APN, promote APN mRNA transcripts and increase the protein expression of Adipo receptor. Meanwhile,AMPKα mRNA and р-AMPKα protein expressions were also increased in piperine treated cells, but both LEP mRNA expression and LepR protein expressions were decreased in piperine treated group. The results indicated that piperine could significantly ameliorate the glucose metabolism disorder in insulin resistance cell models through regulating upstream molecules (APN and LEP) of AMPK signaling pathway, and thus activate the AMPK signaling pathway.
